| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 157 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2019 | Collier Alan Brian | CEO | Buy | 75,000 | $0.02 | $1,211.10 | - | |
| Jun 17, 2019 | Collier Alan Brian | CEO | Buy | 52,000 | $0.01 | $635.50 | - | |
| Jun 7, 2019 | Collier Alan Brian | CEO | Buy | 111,000 | $0.01 | $1,255.70 | - | |
| Jun 4, 2019 | Collier Alan Brian | CEO | Buy | 34,000 | $0.01 | $425.30 | - | |
| Jun 4, 2019 | Collier Alan Brian | CEO | Buy | 191,000 | $0.01 | $2,294.33 | - | |
| May 29, 2019 | Collier Alan Brian | CEO | Buy | 490,500 | $0.01 | $5,180.13 | - | |
| May 24, 2019 | Collier Alan Brian | CEO | Buy | 181,000 | $0.01 | $1,725.48 | - | |
| May 24, 2019 | Collier Alan Brian | CEO | Buy | 374,200 | $0.01 | $3,797.36 | - | |
| May 21, 2019 | Collier Alan Brian | CEO | Buy | 43,000 | $0.01 | $472.40 | - | |
| May 16, 2019 | Collier Alan Brian | CEO | Buy | 81,500 | $0.01 | $1,036.74 | - |